BMC Cancer

official impact factor 3.15

Open Access Highly Access

Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study

Alexandros Ardavanis*, Dimitrios Doufexis, Panteleimon Kountourakis, Savvoula Malliou, Athanasios Karagiannis, Evgenia Kardara, Despina Sykoutri, Margari Charalampia and Gerasimos Rigatos

BMC Cancer 2009, 9:338 doi:10.1186/1471-2407-9-338

Accesses  

  • Last 30 days: 50 accesses
  • Last 365 days: 372 accesses
  • All time: 2227 accesses